Apoptosis and the liver: Relevance for the hepato-biliary-pancreatic surgeon

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 5, Issue 4, 1998, Pages 409-415

  Miyoshi, Hideyuki ^a   Gores, Gregory J ^a  

^a Medical School   (United States)

Author keywords

Cholestasis; Hepatocellular cancer; Ischemia reperfusion injury

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; HUMAN; LIVER DISEASE; LIVER TUMOR; METABOLISM; PATHOLOGY; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032240911     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340050065     Document Type: Article

References (63)

1. Hall PA, Coates PJ, Ansari B, Hopwood D (1994) Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J Cell Sci 107:3569-3577
2. Gobe GC, Axelsen RA, Searle JW (1990) Cellular events in experimental unilateral ischemic renal atrophy and in regeneration after contralateral nephrectomy. Lab Invest 63:770-779
3. Schumer M, Colombel MC, Swaczuk IS, Globe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R (1992) Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838
4. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, Whelan J (1997) Tissue-specific pattern of stress kinase activation in ischemic/reperfusion heart and kidney. J Biol Chem 273:19943-19950
5. Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M (1994) Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75:426-433
6. Itoh G, Tamura J, Suzuki M, Suzuki Y, Ikeda H, Koike M, Nomura M, Jie T, Ito K (1995) DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am J Pathol 146:1325-1332
7. Carraro U, Franceschi C (1997) Apoptosis of skeletal and cardiac muscles and physical exercise. Aging 9:19-34
8. Bromme HJ, Holtz J (1996) Apoptosis in the heart: When and why? Mol Cell Biochem 163-164:261-275
9. Fellman V, Raivio KO (1997) Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr Res 41:599-606
10. Vexler ZS, Roberts TP, Bollen Aw, Derugin N, Arieff AI (1997) Transient cerebral ischemia. Association of apoptosis induction with hypoperfusion. J Clin Inv 99:1453-1459
11. Chopp M, Li Y (1996) Apoptosis in focal cerebral ischemia. Acta Neurochir Suppl 66:21-26
12. Fujimoto K, Hosotani R, Wada M, Lee J, Koshiba T, Miyamato Y, Doi R, Imamura M (1997) Ischemia-reperfusion injury on the pancreas in rats: Identification of acinar cell apoptosis. J Surg Res 71:127-136
13. Schlossberg H, Zhang Y, Dudus L, Engelhardt JF (1996) Expression of c-fos and c-jun during hepatocellular remodeling following ischemia/reperfusion in mouse liver. Hepatology 23:1546-1555
14. Manning FCR, Patierno SR (1996) Apoptosis: Inhibitor or instigator of carcinogenesis? Cancer Invest 14:455-465
15. Que FG, Gores GJ, LaRusso NF (1997) Development and initial application of an in vitro model of apoptosis in rodent cholangiocytes. Am J Physiol 272:G106-G115
16. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501
17. Fadok VA, Voelker DR, Campbell PA, Henson PM (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207-2216
18. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, van Oers MHJ (1994) Annexine V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420
19. Patel T, Gores GJ, Kaufmann SH (1996) The role of proteases during apoptosis. FASEB J 10:587-597
20. Villa P, Kaufmann SH, Earnshaw WC (1997) Caspase and caspase inhibitors. TIBS 22:388-393
21. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43-50
22. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184:1155-1160
23. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
24. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157
25. Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD (1997) Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J 16:4639-4649
26. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178
27. Cohen JJ, Duke RC, Fadock VA, Sellins KS (1992) Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293
28. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
29. Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449-1456
30. Nagata S (1997) Apoptosis by death factor. Cell 88:355-365
31. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:806-809
32. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, Brenner DA (1998) NFאB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 101:802-811
33. Kiston J, Raven T, Jiang Y-P, Goeddel DV, Giles KM, Pun K-T, Grinham CJ, Brown R, Farrow SN (1996) A death-domain-containing receptor that mediates apoptosis. Nature 384:372-375
34. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young JAT (1996) CARl, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87:845-855
35. Kurosawa H, Que FG, Roberts LR, Fesmier PJ, Gores GJ (1997) Hepatocytes in the bile duct-ligated rat express Bcl-2. Am J Physiol 272:01587-01593
36. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
37. Kren BT, Trembley JH, Krajewski S, Behrens TW, Reed JC, Steer CJ (1996) Modulation of apoptosis-associated genes bcl-2, bcl-x and bax during rat liver regeneration. Cell Growth Differ 7:1633-1642
38. Bayly AC, Roberts RA, Dive C (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J Cell Biol 125:197-203
39. Adachi M, Suematsu S, Kondo T, Ogasawara J, Tanaka T, Yoshida N, Nagata S (1995) Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nature Genet 11:294-300
40. Shimamatsu K, Wanless IR (1997) Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 26:343-350
41. Kerr JFR (1971) Shrinkage necrosis: A distinct mode of cellular death. J Pathol 105:13-20
42. Kubota T, Takabe K, Yang M, Sekido H, Endo I, Ichikawa Y, Togo S, Shimada H (1997) Minimum sizes for remnant and transplanted livers in rats. J Hep Bil Pancr Surg 4:398-404
43. Borghi-Scoazec G, Scoazec JY, Durand F, Bernuau J, Belghiti J, Feldmann G, Henin D, Degott C (1997) Apoptosis after ischemia-reperfusion in human liver allograft. Liver Transpl Surg 3:407-415
44. Sasaki H, Matsuno T, Ishikawa T, Ishine N, Sadamori H, Yagi T, Tanaka N (1997) Activation of apoptosis during early phase of reperfusion after liver transplantation. Transplant Proc 29(1-2):406-407
45. Leist M, Gantner F, Jilg S, Wendel A (1995) Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154:1307-1316
46. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146:1220-1234
47. Motoyama S, Minamiya Y, Saito S, Saito R, Matsuzaki I, Abo S, Inaba H, Enomoto K, Kitamura M (1998) Hydrogen peroxide derived from hepatocytes induced sinusoidal endothelial cell apoptosis in perfused hypoxic rat liver. Gastroenterology 114:153-163
48. Shimizu S, Eguchi Y, Kosaka H, Kamiike W, Matsuda H, Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374:811-813
49. Jacobson MD, Raff MC (1995) Programmed cell death and Bcl-2 protection in very low oxygen. Nature 374:814-816
50. Wu G, Tomei LD, Bathurst IC, Zhang F, Hong CB, Issel CJ (1997) Antiapoptotic compound to enhance hypothermic liver preservation. Transplantation 63:803-809
51. Lane DP (1992) p53, guardian of the genome. Nature 358:15-16
52. Müllauer L, Grasl-Kraupp B, Bursch W, Schulte-Hermann R (1996) Transforming growth factor beta 1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Hepatology 23:840-847
53. Sue SR, Chari RS, Kong FM, Mills JJ, Fine RL, Jirtle RL, Meyers WC (1995) Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma. Ann Surg 222:171-178
54. Bedossa P, Peltier E, Terris B, Franco D, Poynard T (1995) Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21:760-765
55. Factor VM, Kao C-Y, Santoni-Rugiu E, Woitach JT, Jensen MR, Thorgeirsson SS (1997) Constitutive expression of mature transforming growthe factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res 57:2089-2095
56. Shirai Y, Kawata S, Tamura S, Ito N, Tsushima H, Takaishi K, Kiso S, Matsuzawa Y (1994) Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases. Cancer 73:2275-2279
57. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R (1990) Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11:847-853
58. Müller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by th CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403-413
59. Strand S, Hofmann WJ, Hug H, Müller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH, Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells. A mechanism of immune evasion. Nature Med 2:1361-1366
60. Patel T, Bronk SF, Gores GJ (1994) Increase of intracellular magnesium promotes glycodeoxycholate-induced apoptosis in rat hepatocytes. J Clin Invest 94:2183-2192
61. 2+ influx during bile salt-induced apoptosis of rat hepatocytes (abstract). Gastroenterology 112:1295
62. Roberts LR, Kurosawa H, Bronk SF, Fesmier PJ, Agellon LB, Leung WY, Mao F, Gores GJ (1997) Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterology 113:1714-1726
63. Rodrigues CMP, Fan G, Ma X, Brites D, Kren DT, Steer CJ (1997) A novel role for ursodeoxycholic acid in modulating apoptosis in rat liver, isolated rat hepatocytes and human hepatoma cells (abstract). Hepatology 26:366